Back to Search
DR. TROY JESSE SCHUMACHER M.D.
M.D.
Family Medicine Physician
NPI: 1215193784IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
14195(NV)
Education
OTHER
Class of 2005
Research & Publications (20)
Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant?
PMID 19576975·Int J Pharm·2010
7-preclinical
High-throughput T-cell epitope discovery through MHC peptide exchange.
PMID 19377960·Methods Mol Biol·2009
8-other
Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.
PMID 19543285·Nat Methods·2009
8-other
Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells.
PMID 19552409·J Am Chem Soc·2009
7-preclinical
Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo.
PMID 19109147·J Immunol·2009
7-preclinical
Class I major histocompatibility complexes loaded by a periodate trigger.
PMID 19655751·J Am Chem Soc·2009
8-other
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008.
PMID 19189103·Cancer Immunol Immunother·2009
6-review
Rotational instability of the knee: internal tibial rotation under a simulated pivot shift test.
PMID 18594847·Arch Orthop Trauma Surg·2009
8-other
Preclinical development of T cell receptor gene therapy.
PMID 19321326·Curr Opin Immunol·2009
6-review
Optimization of intradermal vaccination by DNA tattooing in human skin.
PMID 19301471·Hum Gene Ther·2009
8-other
TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.
PMID 18684947·J Immunol·2008
4-observational
Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigen.
PMID 18922918·Cancer Res·2008
7-preclinical
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
PMID 18308940·Proc Natl Acad Sci U S A·2008
8-other
T-cell receptor gene therapy of established tumors in a murine melanoma model.
PMID 18157006·J Immunother·2008
7-preclinical
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.
PMID 18467010·Vaccine·2008
4-observational
An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease.
PMID 18424760·J Immunol·2008
7-preclinical
GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.
PMID 18606527·Eur J Pharm Biopharm·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1397 S LOOP RD
PAHRUMP, NV 89048 - Phone
- (775) 727-5500
Quick Facts
- NPI
- 1215193784
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile